Read + Share
Amedeo Smart
Independent Medical Education
Tanaka A, Taguchi I, Teragawa H, Ishizaka N, et al. Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial. PLoS Med 2020;17:e1003095.PMID: 32320401
Email
LinkedIn
Facebook
Twitter
Privacy Policy